Covaxx is a biotech company developing diagnostic tests and vaccines designed to cure COVID-19.
Covaxx has announced that their vaccine development efforts will be consolidated under the newly formed holding company, Vaxxinity, Inc. The company is headquartered in Dallas, Texas, and has operations in Asia, Europe, Latin America, and the United States. Vaxxinity has acquired wholly-owned subsidiaries COVAXX and United Neuroscience. Vaxxinity's Board of Directors has been appointed by Lou Reese, the Executive Chairman of COVAXX. Mei Mei Hu, former CEO of COVAXX, has been named CEO of Vaxxinity.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 7, 2020 | Series Unknown | $18.01M | 1 | — | — | Detail |
Apr 3, 2020 | Series Unknown | $14.84M | — | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Ministry of Health and Welfare (Taiwan) | — | Series Unknown |